Rain Therapeutics Initiates Phase 3 MANTRA Clinical Trial of Milademetan for De-differentiated Liposarcoma and Provides Patient Update from Prior Clinical Program

Daniel Sontupe
Market Access

Frank Burrell
Scientific Storytelling

Joey Cohen
Medication Adherence

Bud Bilanich
Success Coach

Pat Purcell
Meeting Engagement

Brenda Snow
Authentic Patient Voice

Matthew Durham
Omnidynamic Marketing

Liz Kane
Impactful Strategy

Stacey Gandler
Brand Nourishment

David Linetsky
Point-of-Care Marketing

Amy Giles
Increasing Engagement

Paul Theisen
Patient Acquisition

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability